nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.0571	0.128	CbGpPWpGaD
Astemizole—CYP2J2—forebrain—attention deficit hyperactivity disorder	0.0437	0.109	CbGeAlD
Astemizole—CYP2J2—cardiovascular system—attention deficit hyperactivity disorder	0.0369	0.0923	CbGeAlD
Astemizole—Fluspirilene—ADRA2A—attention deficit hyperactivity disorder	0.0314	0.203	CrCbGaD
Astemizole—CYP2J2—midbrain—attention deficit hyperactivity disorder	0.0288	0.0721	CbGeAlD
Astemizole—Pimozide—DRD3—attention deficit hyperactivity disorder	0.0257	0.166	CrCbGaD
Astemizole—Fluspirilene—SLC6A4—attention deficit hyperactivity disorder	0.0239	0.155	CrCbGaD
Astemizole—Fluspirilene—DRD2—attention deficit hyperactivity disorder	0.0238	0.154	CrCbGaD
Astemizole—CYP2J2—nervous system—attention deficit hyperactivity disorder	0.0237	0.0592	CbGeAlD
Astemizole—CYP2J2—central nervous system—attention deficit hyperactivity disorder	0.0228	0.057	CbGeAlD
Astemizole—CYP2J2—cerebellum—attention deficit hyperactivity disorder	0.0223	0.0558	CbGeAlD
Astemizole—KCNH2—forebrain—attention deficit hyperactivity disorder	0.0186	0.0465	CbGeAlD
Astemizole—Fluspirilene—HTR2A—attention deficit hyperactivity disorder	0.0184	0.119	CrCbGaD
Astemizole—CYP2J2—brain—attention deficit hyperactivity disorder	0.0181	0.0453	CbGeAlD
Astemizole—Pimozide—DRD2—attention deficit hyperactivity disorder	0.0178	0.115	CrCbGaD
Astemizole—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.0157	0.0393	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0155	0.0349	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0152	0.0342	CbGpPWpGaD
Astemizole—HRH1—forebrain—attention deficit hyperactivity disorder	0.0149	0.0373	CbGeAlD
Astemizole—Pimozide—HTR2A—attention deficit hyperactivity disorder	0.0137	0.0888	CrCbGaD
Astemizole—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0131	0.0293	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0128	0.0287	CbGpPWpGaD
Astemizole—KCNH2—midbrain—attention deficit hyperactivity disorder	0.0123	0.0307	CbGeAlD
Astemizole—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0114	0.0284	CbGeAlD
Astemizole—KCNH2—nervous system—attention deficit hyperactivity disorder	0.0101	0.0253	CbGeAlD
Astemizole—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00973	0.0243	CbGeAlD
Astemizole—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.00951	0.0238	CbGeAlD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0094	0.0211	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00922	0.0207	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00887	0.0199	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00857	0.0193	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0083	0.0187	CbGpPWpGaD
Astemizole—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00817	0.0204	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00816	0.0183	CbGpPWpGaD
Astemizole—HRH1—nervous system—attention deficit hyperactivity disorder	0.0081	0.0202	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00806	0.0181	CbGpPWpGaD
Astemizole—HRH1—central nervous system—attention deficit hyperactivity disorder	0.0078	0.0195	CbGeAlD
Astemizole—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00775	0.0174	CbGpPWpGaD
Astemizole—KCNH2—brain—attention deficit hyperactivity disorder	0.00772	0.0193	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00751	0.0169	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00721	0.0162	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00702	0.0158	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00698	0.0157	CbGpPWpGaD
Astemizole—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.0069	0.0173	CbGeAlD
Astemizole—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00686	0.0154	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00678	0.0152	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00631	0.0142	CbGpPWpGaD
Astemizole—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00626	0.0156	CbGeAlD
Astemizole—HRH1—brain—attention deficit hyperactivity disorder	0.00619	0.0155	CbGeAlD
Astemizole—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00616	0.0154	CbGeAlD
Astemizole—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00603	0.0151	CbGeAlD
Astemizole—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00593	0.0148	CbGeAlD
Astemizole—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0058	0.0145	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00572	0.0129	CbGpPWpGaD
Astemizole—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00539	0.0135	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00526	0.0118	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00503	0.0113	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00499	0.0112	CbGpPWpGaD
Astemizole—CYP2J2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00496	0.0111	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00492	0.0111	CbGpPWpGaD
Astemizole—CYP2D6—brain—attention deficit hyperactivity disorder	0.00471	0.0118	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00458	0.0103	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00458	0.0103	CbGpPWpGaD
Astemizole—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00443	0.0111	CbGeAlD
Astemizole—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00442	0.00993	CbGpPWpGaD
Astemizole—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00427	0.0107	CbGeAlD
Astemizole—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00425	0.00955	CbGpPWpGaD
Astemizole—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00417	0.0104	CbGeAlD
Astemizole—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0041	0.00921	CbGpPWpGaD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00375	0.00842	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00359	0.00807	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00344	0.00773	CbGpPWpGaD
Astemizole—ABCB1—brain—attention deficit hyperactivity disorder	0.00339	0.00847	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00332	0.00746	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00309	0.00694	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.003	0.00673	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00294	0.0066	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00292	0.00655	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00287	0.00646	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00281	0.0063	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00271	0.00608	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00257	0.00577	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00256	0.00575	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00252	0.00565	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00218	0.00489	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00216	0.00486	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00206	0.00462	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00204	0.00457	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.002	0.0045	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00199	0.00447	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00198	0.00444	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00196	0.00439	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00193	0.00433	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00192	0.0043	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00188	0.00422	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00178	0.004	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00174	0.00392	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00165	0.00372	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00165	0.0037	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0016	0.0036	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00157	0.00354	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00156	0.00349	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00152	0.00342	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0015	0.00336	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00149	0.00334	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00145	0.00325	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00145	0.00325	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00144	0.00323	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00143	0.00321	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00142	0.00319	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00142	0.00319	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00142	0.00318	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0014	0.00314	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00137	0.00308	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00135	0.00303	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00135	0.00303	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00133	0.00299	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00133	0.00298	CbGpPWpGaD
Astemizole—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00131	0.00295	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0013	0.00292	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00129	0.00289	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00126	0.00283	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00124	0.00279	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00117	0.00264	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00261	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00113	0.00255	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00248	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00108	0.00243	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00243	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00108	0.00242	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00105	0.00235	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00103	0.00231	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00231	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00102	0.0023	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00102	0.00228	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00228	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00101	0.00228	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00101	0.00227	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00225	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000983	0.00221	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000963	0.00216	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000945	0.00212	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000884	0.00199	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000869	0.00195	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00086	0.00193	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000854	0.00192	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000828	0.00186	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00082	0.00184	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000751	0.00169	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00069	0.00155	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000682	0.00153	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000674	0.00151	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000669	0.0015	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000664	0.00149	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000662	0.00149	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000656	0.00147	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00061	0.00137	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000596	0.00134	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000593	0.00133	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000593	0.00133	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000591	0.00133	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000581	0.0013	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000581	0.0013	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000573	0.00129	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00057	0.00128	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000566	0.00127	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000566	0.00127	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000557	0.00125	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000554	0.00124	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000536	0.00121	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000534	0.0012	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000527	0.00118	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000521	0.00117	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000517	0.00116	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000485	0.00109	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000469	0.00105	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000452	0.00102	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000447	0.001	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000431	0.000969	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000431	0.000967	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000421	0.000946	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000409	0.000919	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000409	0.000919	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000403	0.000905	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000402	0.000904	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000374	0.000841	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000374	0.00084	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000369	0.000828	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000352	0.000791	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000343	0.00077	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00034	0.000765	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00034	0.000763	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000327	0.000735	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000327	0.000734	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000317	0.000712	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.0007	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000699	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000309	0.000693	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000309	0.000693	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000308	0.000691	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000304	0.000682	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000291	0.000653	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000291	0.000653	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000287	0.000644	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000286	0.000643	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000282	0.000634	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000275	0.000619	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000266	0.000597	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000248	0.000557	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000554	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000246	0.000553	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000528	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000232	0.000522	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000221	0.000497	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000201	0.000451	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00019	0.000427	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00019	0.000427	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000187	0.00042	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.00042	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000417	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000176	0.000396	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000175	0.000393	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.000391	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000152	0.000341	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000147	0.00033	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000325	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000259	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000114	0.000257	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000106	0.000239	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000106	0.000239	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	8.02e-05	0.00018	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.56e-05	0.00017	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.94e-05	0.000111	CbGpPWpGaD
